244 - Case-Based Gu(ID)lines: Adult Diabetes-Related Foot Infections, Pediatric Acute Bacterial Arthritis and Antimicrobial Resistance

Saturday, October 19, 2024

1:45 PM – 3:00 PM US PT

Location: Petree C

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Sara Rogers, DNP, AGACNP-BC, AGPCNP-BC (she/her/hers)

Infectious Disease Nurse Practitioner
Infectious Diseases and Internal Medicine Associates
Albuquerque, NM, United States
Ravi Jhaveri, MD

Professor of Pediatrics
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, IL, United States

Faculty(s)

Eric Senneville, MD PhD (he/him/his)

Pr.
CH Tourcoing, CHRU Lille
Tourcoing, Nord-Pas-de-Calais, France
John Bradley, MD (he/him/his)

Distinguished Professor of Pediatrics
Pediatrics
University of San Diego School of Medicine, Rady Children's Hospital
San Deigo, CA, United States
Robert Bonomo, MD (he/him/his)

Associate Chief of Staff for Academic Affairs
Division of Medicine
Case Western Reserve University/ Louis Stokes Cleveland VA Medical Center
Cleveland, OH, United States

Disclosure(s):

Sara Rogers, DNP, AGACNP-BC, AGPCNP-BC: No financial relationships to disclose

Ravi Jhaveri, MD: AstraZenca: Advisor/Consultant (Ongoing); CSL Seqirus: Advisor/Consultant (Ongoing); Gilead Biosciences: Advisor/Consultant (Ongoing); GSK: Grant/Research Support (Ongoing); Pediatric Infectious Diseases Society: editorial stipend (Ongoing); Sanofi Pasteur LLC: Advisor/Consultant (Ongoing); UpToDate Wolters Kluwer Health: royalties (Ongoing)

Eric C. Senneville, MD PhD: AdvanzPharma: Advisor/Consultant (Ongoing), Honoraria (Ongoing); bioMérieux: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Menarini Ricerche S.p.A.: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Shionogi Pharmacovigilance Center Co., Ltd.: Advisor/Consultant (Ongoing), Honoraria (Ongoing)

John S. Bradley, MD: No financial relationships to disclose

Robert A. Bonomo, MD: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

identify key updates in the classification and diagnostic frameworks of adult diabetes-related foot infections;
analyze important imaging, laboratory, and clinical investigations required to accurately diagnose pathogens causing acute bacterial arthritis (aba) in all pediatric age groups;
describe the latest recommendations for the treatment of antimicrobial resistant gram-negative infections.

Presentations:

1:45 PM – 2:10 PM US PT

IWGDF/IDSA Guidelines on the diagnosis and treatment of diabetes-related foot infections
Speaker: Eric C. Senneville, MD PhD (he/him/his) – CH Tourcoing, CHRU Lille
2:10 PM – 2:35 PM US PT

Acute Bacterial Arthritis in Kids: The first IDSA/PIDS Guidelines have finally arrived
Speaker: Archana Chatterjee, MD, PhD – Rosalind Franklin University
Speaker: John S. Bradley, MD (he/him/his) – University of San Diego School of Medicine, Rady Children's Hospital
2:35 PM – 3:00 PM US PT

IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
Speaker: Robert A. Bonomo, MD (he/him/his) – Case Western Reserve University/ Louis Stokes Cleveland VA Medical Center